Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Advances in Inflammatory Bowel Diseases (AIBD) 2019
December 12 - 14, 2019; Orlando, Florida
December 12 - 14, 2019Orlando, Florida
AIBD 2019Biosimilar for Crohn's Noninferior to AdalimumabA patent dispute means that the marketing of a biosimilar for patients with inflammatory bowel disease will be delayed, despite approval by the US Food and Drug Administration, investigators report.
Anti-TNF Agents Linked to Increased Risk for IBDA new study finds that patients with autoimmune disease treated with anti- tumor necrosis factor alpha have an increased risk
of developing inflammatory bowel disease.
Medscape Medical News, Jul 15, 2019
Biologics in IBD: More Thoughtful Use Could Improve OutcomesThe marketplace introduction of infliximab for the treatment of IBD did not reduce hospitalization or surgery rates in a large
population of patients with Crohn disease and ulcerative colitis.
Medscape Medical News, Jun 20, 2019
Treating Depression May Mitigate IBD Risk, Study ShowsPatients with depression are at increased risk of developing ulcerative colitis and Crohn's disease, but treatment with antidepressants
may offer some protection.
